The Cache County Study on Memory in Aging: Factors affecting risk of Alzheimer's disease and its progression after onset

International Review of Psychiatry

Volumn 25, Issue 6, 2013, Pages 673-685

  Tschanz, Joann T ^a   Norton, Maria C ^a   Zandi, Peter P ^b   Lyketsos, Constantine G ^c  

^a UTAH STATE UNIVERSITY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; APOLIPOPROTEIN E; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAROTENE; CHOLESTEROL; CONJUGATED ESTROGEN; CYANOCOBALAMIN; DIURETIC AGENT; ESTROGEN; FOLIC ACID; GESTAGEN; HORMONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEDROXYPROGESTERONE ACETATE; MEMANTINE; NONSTEROID ANTIINFLAMMATORY AGENT; PYRIDOXINE;

AGING; ALZHEIMER DISEASE; ANGINA PECTORIS; APATHY; ATHEROSCLEROSIS; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HIGH RISK POPULATION; HORMONAL THERAPY; HUMAN; HYPERTENSION; INCIDENCE; LIFE EVENT; LIFESPAN; LIFESTYLE; LONGITUDINAL STUDY; MEDICAL LITERATURE; MEMORY; MENOPAUSE; MENTAL DISEASE; MENTAL STRESS; MINI MENTAL STATE EXAMINATION; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCREENING; SYSTOLIC HYPERTENSION; TREATMENT DURATION; UNITED STATES; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; AGING; ALZHEIMER DISEASE; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; MALE; MEMORY; PREVALENCE; PROSPECTIVE STUDIES; RISK FACTORS; STRESS, PSYCHOLOGICAL; UTAH;

EID: 84892753333     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2013.849663     Document Type: Review

References (145)

1. Aalten, P., de Vugt, M.E., Lousberg, R., Korten, E., Jaspers, N., Senden, B., ... Verhey, F.R. (2003). Behavioral problems in dementia: A factor analysis of the neuropsychiatric inventory. Dementia and Geriatric Cognitive Disorders, 15, 99-105.
2. Adak, S., Illouz, K., Gorman, W., Tandon, R., Zimmerman, E. A., Guariglia, R., ... Kaye, J.A. (2004). Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology, 63, 108-114.
3. ADAPT Research Group. (2006). Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's disease anti-inflammatory prevention trial (ADAPT). PLoS Clinical Trials, 1, e33.
4. ADAPT Research Group, Lyketsos, C.G., Breitner, J.C., Green, R.C., Martin, B.K., Meinert, C., ... Sabbagh, M. (2007). Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology, 68, 1800-1808.
5. Aguero-Torres, H., Fratiglioni, L., Guo, Z., Viitanen, M. & Winblad, B. (1998a). Prognostic factors in very old demented adults: A seven-year follow-up from a population-based survey in Stockholm. Journal of the American Geriatrics Society 46, 444-452.
6. Aguero-Torres, H., Fratiglioni, L. & Winblad, B. (1998b). Natural history of Alzheimer's disease and other dementias: Review of the literature in the light of the findings from the Kungsholmen Project. International Journal of Geriatric Psychiatry, 13, 755-766.
7. Aisen, P.S., Schmeidler, J. & Pasinetti, G.M. (2002). Randomized pilot study of nimesulide treatment in Alzheimer's disease. Neurology, 58, 1050-1054.
8. Aisen, P.S., Schafer, K.A., Grundman, M., Pfeiffer, E., Sano, M., Davis, K.L., ... Thal, L.J. (2003). Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: A randomized controlled trial. Journal of the American Medical Association, 289, 2819-2826.
9. Andersen-Ranberg, K., Vasegaard, L. & Jeune, B. (2001). Dementia is not inevitable: A population-based study of Danish centenarians. Journal of Gerontology B Psychological Science, 56, P152-159.
10. Anthony, J.C., Breitner, J.C., Zandi, P.P., Meyer, M.R., Jurasova, I., Norton, M.C. & Stone, S.V. (2000). Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County Study. Neurology, 54, 2066-2071.
11. Asthana, S., Baker, L.D., Craft, S., Stanczyk, F.Z., Veith, R.C., Raskind, M.A. & Plymate, S.R. (2001). High-dose estradiol improves cognition for women with AD: Results of a randomized study. Neurology, 57, 605-612.
12. Barnhart, R.L., van Belle, G., Edland, S.D. & Larson, E. (1997). Referral bias in Alzheimer's disease. Journal of Clinical Epidemiology, 50, 365-366.
13. Behl, P., Stefurak, T.L. & Black, S.E. (2005). Progress in clinical neurosciences: Cognitive markers of progression in Alzheimer's disease. Canadian Journal of Neurological Sciences, 32, 140-151.
14. Borenstein, A.R., Wu, Y., Mortimer, J.A., Schellenberg, G.D., McCormick, W.C., Bowen, J.D., ... Larson, E.B. (2005). Developmental and vascular risk factors for Alzheimer's disease. Neurobiolology of Aging, 26, 325-334.
15. Bosch, J., Yusuf, S., Pogue, J., Sleight, P., Lonn, E., Rangoonwala, B., ... Probstfield, J. (2002). Use of ramipril in preventing stroke: Double blind randomised trial. British Medical Journal, 324, 699-702.
16. Bowler, J.V., Munoz, D.G., Merskey, H., & Hachinski, V. (1998). Factors affecting the age of onset and rate of progression of Alzheimer's disease. Journal of Neurology, Neurosurgery and Psychiatry, 65, 184-190.
17. Breitner, J.C. & Zandi, P.P. (2003). Effects of estrogen plus progestin on risk of dementia. Journal of the American Medical Association, 290, 1706-1707.
18. Breitner, J.C., Haneuse, S.J., Walker, R., Dublin, S., Crane, P.K., Gray, S. L., Larson, E.B. (2009). Risk of dementia and AD with prior exposure to NSAIDs in an elderly communitybased cohort. Neurology, 72, 1899-1905.
19. Breitner, J.C.S. & Miech, R.A. (2000). ApoE-E4 count predicts age when prevalence of AD increases, then declines-Correction. Neurology, 55, 161-162.
20. Breitner, J.C., Welsh, K.A., Gau, B.A., McDonald, W.M., Steffens, D.C., Saunders, A.M., ... Folstein, M.F. (1995). Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of Aging Twin Veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Archives of Neurology, 52, 763-771.
21. Brenner, D.E., Kukull, W.A., Stergachis, A., van Belle, G., Bowen, J.D., McCormick, W.C., ... Larson, E.B. (1994). Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study. American Journal of Epidemiology, 140, 262-267.
22. Brinton, R.D. & Nilsen, J. (2003). Effects of estrogen plus progestin on risk of dementia. Journal of the American Medical Association, 290, 1706.
23. Carlson, M.C., Zandi, P.P., Plassman, B.L., Tschanz, J.T., Welsh-Bohmer, K.A., Steffens, D.C., ... Breitner, J.C. (2001). Hormone replacement therapy and reduced cognitive decline in older women: The Cache County Study. Neurology, 57, 2210-2216.
24. Corrada, M.M., Brookmeyer, R., Paganini-Hill, A., Berlau, D. & Kawas, C.H. (2010). Dementia incidence continues to increase with age in the oldest old: The 90 - study. Annals of Neurolology, 67, 114-121.
25. Farrer, L.A., Cupples, L.A., Haines, J.L., Hyman, B., Kukull, W.A., Mayeux, R., ... Van Duijn, C.M. (1997). Effects of age, sex, and ethnicity on the association between apolipoprotein e genotype and alzheimer disease. A metaanalysis. ApoE and Alzheimer disease meta analysis consortium. Journal of the American Medical Association, 278, 1349-1356.
26. Fauth, E., Hess, K., Piercy, K., Norton, M., Corcoran, C., Rabins, P., ... Tschanz, J. (2012). Caregivers'relationship closeness with the person with dementia predicts both positive and negative outcomes for caregivers'physical health and psychological well-being. Aging and Mental Health, 16, 699-711.
27. Fauth, E.B., Schwartz, S., Tschanz, J.T., Ostbye, T., Corcoran, C. & Norton, M.C. (2013). Baseline disability in activities of daily living predicts dementia risk even after controlling for baseline global cognitive ability and depressive symptoms. International Journal of Geriatric Psychiatry, 28, 597-606.
28. Forette, F., Seux, M.L., Staessen, J.A., Thijs, L., Babarskiene, M.R., Babeanu, S., ... Birkenhager, W.H. (2002). The prevention of dementia with antihypertensive treatment: New evidence from the systolic hypertension in Europe (Syst-Eur) study. Archives of Internal Medicine, 162, 2046-2052.
29. Forette, F., Seux, M.L., Staessen, J.A., Thijs, L., Birkenhager, W.H., Babarskiene, M.R., ... Fagard, R. (1998). Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet, 352, 1347-1351.
30. Frisoni, G.B., Rozzini, L., Gozzetti, A., Binetti, G., Zanetti, O., Bianchetti, A., ... Cummings, J.L. (1999). Behavioral syndromes in alzheimer's disease: Description and correlates. Dementia and Geriatric Cognitive Disorders, 10, 130-138.
31. Ganguli, M., Snitz, B.E., Saxton, J.A., Chang, C.C., Lee, C.W., Vander Bilt, J., ... Petersen, R.C. (2011). Outcomes of mild cognitive impairment by definition: A population study. Archives of Neurology, 68, 761-767.
32. Gao, S., Hendrie, H.C., Hall, K.S. & Hui, S. (1998). The relationships between age, sex, and the incidence of dementia and alzheimer disease: A meta-analysis. Archives of General Psychiatry, 55, 809-815.
33. Garre-Olmo, J., Lopez-Pousa, S., Vilalta-Franch, J., De Gracia Blanco, M. & Vilarrasa, A.B. (2010). Grouping and trajectories of the neuropsychiatric symptoms in patients with Alzheimer's disease, part I: Symptom clusters. Journal of Alzheimer's Disease, 22, 1157-1167.
34. Graham, J.E., Rockwood, K., Beattie, B.L., Eastwood, R., Gauthier, S., Tuokko, H. & Mcdowell, I. (1997). Prevalence and severity of cognitive impairment with and without dementia in an elderly population. Lancet, 349, 1793-1796.
35. Greene, D., Tschanz, J.T., Smith, K.R., Ostbye, T., Corcoran, C., Welsh-Bohmer, K.A. & Norton, M.C. (2013). Impact of offspring death on cognitive health in late life. The Cache County Study. American Journal of Geriatric Psychiatry, doi: 10.1016/j.jagp.2013.05.002.
36. Gustafson, D. (2008). A life course of adiposity and dementia. European Journal of Pharmacology, 585, 163-175.
37. Hajjar, I., Schumpert, J., Hirth, V., Wieland, D. & Eleazer, G.P. (2002). The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. Journals of Gerontology A Biological & Medical Science, 57, M414-418.
38. Hall, C.B., Verghese, J., Sliwinski, M., Chen, Z., Katz, M., Derby, C. & Lipton, R.B. (2005). Dementia incidence may increase more slowly after age 90: Results from the Bronx Aging Study. Neurology, 65, 882-886.
39. Hayden, K.M. & Welsh-Bohmer, K.A. (2012). Epidemiology of cognitive aging and Alzheimer's disease: Contributions of the Cache County Utah Study of Memory, Health and Aging. Current Topics in Behavioral Neuroscience. Berlin: Springer.
40. Hayden, K.M., Zandi, P.P., Khachaturian, A.S., Szekely, C.A., Fotuhi, M., Norton, M.C., ... Welsh-Bohmer, K.A. (2007). Does NSAID use modify cognitive trajectories in the elderly The Cache County Study. Neurology, 69, 275-282.
41. Hayden, K.M., Zandi, P.P., Lyketsos, C.G., Khachaturian, A.S., Bastian, L.A., Charoonruk, G., ... Welsh-Bohmer, K.A. (2006). Vascular risk factors for incident Alzheimer disease and vascular dementia: The Cache County Study. Alzheimer Disease and Associated Disorders, 20, 93-100.
42. Henderson, V.W., Paganini-Hill, A., Miller, B.L., Elble, R.J., Reyes, P.F., Shoupe, D., ... Farlow, M.R. (2000). Estrogen for Alzheimer's disease in women: Randomized, doubleblind, placebo-controlled trial. Neurology, 54, 295-301.
43. Hofman, A., Ott, A., Breteler, M.M., Bots, M.L., Slooter, A.J., Van Harskamp, ... Grobbee, D.E. (1997). Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet, 349, 151-154.
44. Jellinger, K.A. (2006). Clinicopathological analysis of dementia disorders in the elderly-An update. Journal of Alzheimer's Disease, 9 (Suppl.3), 61-70.
45. Jick, H., Zornberg, G.L., Jick, S.S., Seshadri, S. & Drachman, D.A. (2000). Statins and the risk of dementia. Lancet, 356, 1627-1631.
46. Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., ... Metter, E. (1997). A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology, 48, 1517-1521.
47. Kawas, C.H. & Corrada, M.M. (2006). Alzheimer's and dementia in the oldest-old: A century of challenges. Current Alzheimer Research, 3, 411-419.
48. Khachaturian, A.S., Corcoran, C.D., Mayer, L.S., Zandi, P.P. & Breitner, J.C. (2004). Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study. Archives of General Psychiatry, 61, 518-524.
49. Khachaturian, A.S., Zandi, P.P., Lyketsos, C.G., Hayden, K.M., Skoog, I., Norton, M.C. ... Breitner, J.C. (2006). Antihypertensive medication use and incident Alzheimer disease: The Cache County Study. Archives of Neurology, 63, 686-692.
50. Kivipelto, M., Helkala, E.L., Laakso, M.P., Hanninen, T., Hallikainen, M., Alhainen, K., ... Nissinen, A. (2001). Midlife vascular risk factors and Alzheimer's disease in later life: Longitudinal, population based study. British Medical Journal, 322, 1447-1451.
51. Larrieu, S., Letenneur, L., Orgogozo, J.M., Fabrigoule, C., Amieva, H., Le Carret, N., ... Dartigues, J.F. (2002). Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology, 59, 1594-1599.
52. Launer, L.J., Ross, G.W., Petrovitch, H., Masaki, K., Foley, D., White, L.R. & Havlik, R.J. (2000). Midlife blood pressure and dementia: The Honolulu-Asia Aging Study. Neurobiology of Aging, 21, 49-55.
53. Leoutsakos, J.M., Han, D., Mielke, M.M., Forrester, S.N., Tschanz, J.T., Corcoran, C.D., ... Lyketsos, C.G. (2012). Effects of general medical health on Alzheimer's progression: The Cache County Dementia Progression Study. International Psychogeriatrics, 24, 1561-1570.
54. Li, G., Higdon, R., Kukull, W.A., Peskind, E., Van Valen Moore, K., Tsuang, D., ... Larson, E.B. (2004). Statin therapy and risk of dementia in the elderly: A community-based prospective cohort study. Neurology, 63, 1624-1628.
55. Lopez, O.L., Kuller, L.H., Becker, J.T., Dulberg, C., Sweet, R.A., Gach, H.M. & Dekosky, S.T. (2007). Incidence of dementia in mild cognitive impairment in the Cardiovascular Health Study Cognition Study. Archives of Neurology, 64, 416-420.
56. Luchsinger, J.A., Reitz, C., Honig, L.S., Tang, M.X., Shea, S. & Mayeux, R. (2005). Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology, 65, 545-551.
57. Luchsinger, J.A., Tang, M.X., Shea, S. & Mayeux, R. (2003). Antioxidant vitamin intake and risk of Alzheimer disease. Archives of Neurology, 60, 203-208.
58. Lyketsos, C.G., Carrillo, M.C., Ryan, J.M., Khachaturian, A.S., Trzepacz, P., Amatniek, J., ... Miller, D.S. (2011). Neuropsychiatric symptoms in Alzheimer's Disease. Alzheimers & Dementia, 7, 532-9.
59. Lyketsos, C.G., Sheppard, J.M., Steinberg, M., Tschanz, J.A., Norton, M.C., Steffens, D.C. & Breitner, J.C. (2001). Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: The Cache County Study. International Journal of Geriatrric Psychiatry, 16, 1043-1053.
60. Lyketsos, C.G., Toone, L., Tschanz, J., Rabins, P.V., Steinberg, M., Onyike, C.U., ... Williams, M. (2005). Population-based study of medical comorbidity in early dementia and ' cognitive impairment, no dementia (CIND) ': Association with functional and cognitive impairment: The Cache County Study. American Journal of Geriatric Psychiatry, 13, 656-664.
61. Martin, B.K., Szekely, C., Brandt, J., Piantadosi, S., Breitner, J.C., Craft, S., ... Mullan, M. (2008). Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): Results of a randomized, controlled trial of naproxen and celecoxib. Archives of Neurology, 65, 896-905.
62. Miech, R.A., Breitner, J.C., Zandi, P.P., Khachaturian, A.S., Anthony, J.C. & Mayer, L. (2002). Incidence of AD may decline in the early 90s for men, later for women: The Cache County Study. Neurology, 58, 209-218.
63. Mielke, M.M., Leoutsakos, J.M., Corcoran, C.D., Green, R.C., Norton, M.C., Welsh-Bohmer, K.A., ... Lyketsos, C.G. (2012a). Effects of food and drug administration-approved medications for Alzheimer's Disease on clinical progression. Alzheimer's and Dementia, 8, 180-187.
64. Mielke, M.M., Leoutsakos, J.M., Tschanz, J.T., Green, R.C., Tripodis, Y., Corcoran, C.D., ... Lyketsos, C.G., 2012b. Interaction between vascular factors and the ApoE epsilon4 allele in predicting rate of progression in Alzheimer's Disease. Journal of Alzheimer's Disease, 26, 127-134.
65. Mielke, M.M., Rosenberg, P.B., Tschanz, J., Cook, L., Corcoran, C., Hayden, K.M., ... Lyketsos, C.G. (2007). Vascular factors predict rate of progression in Alzheimer Disease. Neurology, 69, 1850-1858.
66. Mitchell, A.J. & Shiri-Feshki, M. (2009). Rate of progression of mild cognitive impairment to dementia-Meta-analysis of 41 robust inception cohort studies. Acta Psychiatrica Scandinavica, 119, 252-265.
67. Moceri, V.M., Kukull, W.A., Emanual, I., Van Belle, G., Starr, J.R., Schellenberg, G.D., ... Larson, E.B. (2001). Using census data and birth certificates to reconstruct the early-life socioeconomic environment and the relation to the develo pment of Alzheimer's Disease. Epidemiology, 12, 383-389.
68. Moceri, V.M., Kukull, W.A., Emanuel, I., Van Belle, G. & Larson, E.B. (2000). Early-life risk factors and the development of Alzheimer's disease. Neurology, 54, 415-420.
69. Morris, M.C., Beckett, L.A., Scherr, P.A., Hebert, L.E., Bennett, D.A., Field, T.S. & Evans, D.A. (1998). Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease. Alzheimer Disease and Associated Disorders, 12, 121-126.
70. Morris, M.C., Evans, D.A., Bienias, J.L., Tangney, C.C., Bennett, D.A., Wilson, R.S., ... Schneider, J. (2003). Consumption of fish and n-3 fatty acids and risk of incident Alzheimer disease. Archives of Neurology, 60, 940-946.
71. Morris, M.C., Evans, D.A., Tangney, C.C., Bienias, J.L. & Wilson, R.S. (2005). Fish consumption and cognitive decline with age in a large community study. Archives of Neurology, 62, 1849-1853.
72. Mortimer, J.A., Ebbitt, B., Jun, S.P. & Finch, M.D. (1992). Predictors of cognitive and functional progression in patients with probable Alzheimer's disease. Neurology, 42, 1689-1696.
73. MRC CFAS (Medical Research Council Cognitive Function and Aging Group). (2001). Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet, 357, 169-175.
74. Mulnard, R.A., Cotman, C.W., Kawas, C., Van Dyck, C.H., Sano, M., Doody, R., ... Thal, L.J. (2000). Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: A randomized controlled trial. Alzheimer's Disease Cooperative Study. Journal of the American Medical Association, 283, 1007-1015.
75. Murray, C., Michaud, C., Mckenna, M. & Marks, J. (1998). U.S. Patterns of mortality by county and race: 1965-1994. Cambridge, MA: Harvard School of Public Health.
76. Nelson, C., Wengreen, H.J., Munger, R.G. & Corcoran, C.D. (2009). Dietary folate, vitamin B12, vitamin B6 and incident Alzheimer's disease: The Cache County Memory, Health and Aging Study. Journal of Nutrition, Health and Aging, 13, 899-905.
77. Norton, M.C., Clark, C., Fauth, E.B., Piercy, K.W., Pfister, R., Green, R.C., ... Tschanz, J.T. (2013a). Caregiver personality predicts rate of cognitive decline in a community sample of persons with Alzheimer's disease. The Cache County Dementia Progression Study. International Psychogeriatrics 25, 1629-1637.
78. Norton, M.C., Dew, J., Smith, H., Fauth, E., Piercy, K.W., Breitner, J.C., ... Welsh-Bohmer, K. (2012). Lifestyle behavior pattern is associated with different levels of risk for incident dementia and Alzheimer's disease: The Cache County Study. Journal of the American Geriatrics Society, 60, 405-412.
79. Norton, M.C., Ostbye, T., Smith, K.R., Munger, R.G. & Tschanz, J.T. (2009a). Early parental death and late-life dementia risk: Findings from the Cache County Study. Age and Ageing, 38, 340-343.
80. Norton, M.C., Piercy, K.W., Rabins, P.V., Green, R.C., Breitner, J.C., Ostbye, T., ... Tschanz, J.T. (2009b). Caregiver- recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. Journals of Gerontology B Psychological Sciences, 64, 560-568.
81. Norton, M.C., Smith, K.R., Ostbye, T., Tschanz, J.T., Corcoran, C., Schwartz, S., ... Welsh-Bohmer, K.A. (2010). Greater risk of dementia when spouse has dementia The Cache County Study. Journal of the American Geriatrics Society, 58, 895-900.
82. Norton, M.C., Smith, K.R., Ostbye, T., Tschanz, J.T., Corcoran, C., Schwartz, S., ... Welsh-Bohmer, K.A. (2013b). Correction: Greater risk of dementia when spouse has dementia The Cache County Study. Journal of the American Geriatric Society, 61, 1642.
83. Norton, M.C., Smith, K.R., Ostbye, T., Tschanz, J.T., Corcoran, C., Schwartz, S., ... Breitner, J.C.S. (2011). Early parental death and remarriage of widowed parents as risk factors for Alzheimer's disease. American Journal of Geriatric Psychiatry, 19, 814-824.
84. Notkola, I.L., Sulkava, R., Pekkanen, J., Erkinjuntti, T., Ehnholm, C., Kivinen, P., ... Nissinen, A. (1998). Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology, 17, 14-20.
85. Ott, A., Stolk, R.P., Van Harskamp, F., Pols, H.A., Hofman, A. & Breteler, M.M. (1999). Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology, 53, 1937-1942.
86. Peltz, C.B., Corrada, M.M., Berlau, D.J. & Kawas, C.H. (2011). Incidence of dementia in oldest-old with amnestic MCI and other cognitive impairments. Neurology, 77, 1906-1912.
87. Persson, G. & Skoog, I. (1996). A prospective population study of psychosocial risk factors for late onset dementia. International Journal of Geriatric Psychiatry, 11, 15-22.
88. Peters, M.E., Rosenberg, P.B., Steinberg, M., Norton, M.C., Welsh-Bohmer, K.A., Hayden, K.M., ... Lyketsos, C.G. (2013). Neuropsychiatric symptoms as risk factors for progression from cind to dementia: The Cache County Study. American Journal of Geriatric Psychiatry, 21, 1116-1124.
89. Peters, M.E., Rosenberg, P.B., Steinberg, M., Tschanz, J.T., Norton, M.C., Welsh-Bohmer, K.A., ... Lyketsos, C.G. (2012). Prevalence of neuropsychiatric symptoms in CIND and its subtypes: The Cache County Study. American Journal of Geriatric Psychiatry, 20, 416-424.
90. Peters, R., Beckett, N., Forette, F., Tuomilehto, J., Clarke, R., Ritchie, C., ... Bulpitt, C. (2008). Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial Cognitive Function Assessment (HYVET-cog): A double-blind, placebo controlled trial. Lancet Neurology, 7, 683-689.
91. Petersen, R.C., Thomas, R.G., Grundman, M., Bennett, D., Doody, R., Ferris, S., ... Thal, L.J. (2005). Vitamin E and donepezil for the treatment of mild cognitive impairment. New England Journal of Medicine, 352, 2379-2388.
92. Piercy, K.W., Fauth, E.B., Norton, M.C., Pfister, R., Corcoran, C.D., Rabins, P.V., ... Tschanz, J.T. (2013). Predictors of dementia caregiver depressive symptoms in a population: The Cache County Dementia Progression Study. Journals of Gerontology B Psychological Sciences Social Sciences, 68, 921-926.
93. Plassman, B.L., Langa, K.M., Fisher, G.G., Heeringa, S.G., Weir, D.R., Ofstedal, M.B., ... Wallace, R.B. (2007). Prevalence of dementia in the United States: The Aging, Demographics, and Memory Study. Neuroepidemiology, 29, 125-132.
94. Quinn, J.F., Raman, R., Thomas, R.G., Yurko-Mauro, K., Nelson, E.B., Van Dyck, C., ... Aisen, P.S. (2010). Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial. Journal of the American Medical Association, 304, 1903-1911.
95. Rabins, P.V., Schwartz, S., Black, B.S., Corcoran, C., Fauth, E., Mielke, M., ... Tschanz, J. (2013). Predictors of progression to severe Alzheimer's disease in an incidence sample. Alzheimer's and Dementia, 9, 204-207.
96. Rapp, S.R., Espeland, M.A., Shumaker, S.A., Henderson, V.W., Brunner, R.L., Manson, J.E., ... Bowen, D. (2003). Effect of estrogen plus progestin on global cognitive function in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association, 289, 2663-2672.
97. Rea, T.D., Breitner, J.C., Psaty, B.M., Fitzpatrick, A.L., Lopez, O.L., Newman, A.B., ... Kuller, L.H. (2005). Statin use and the risk of incident dementia: The Cardiovascular Health Study. Archives of Neurology, 62, 1047-1051.
98. Reines, S.A., Block, G.A., Morris, J.C., Liu, G., Nessly, M.L., Lines, C.R., ... Baranak, C.C. (2004). Rofecoxib: No effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study. Neurology, 62, 66-71.
99. Reitz, C., Den Heijer, T., Van Duijn, C., Hofman, A. & Breteler, M.M. (2007). Relation between smoking and risk of dementia and Alzheimer disease: The Rotterdam Study. Neurology, 69, 998-1005.
100. Resnick, S.M. & Henderson, V.W. (2002). Hormone therapy and risk of Alzheimer disease: A critical time. Journal of the American Medical Association, 288, 2170-2172.
101. Rockwood, K., Kirkland, S., Hogan, D.B., Macknight, C., Merry, H., Verreault, R., ... Mcdowell, I. (2002). Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. Archives of Neurology, 59, 223-227.
102. Rosenberg, P.B., Mielke, M.M., Han, D., Leoutsakos, J.S., Lyketsos, C.G., Rabins, P.V., ... Tschanz, J.T. (2012). The association of psychotropic medication use with the cognitive, functional, and neuropsychiatric trajectory of Alzheimer's disease. International Journal of Geriatric Psychiatry, 27, 1248-1257.
103. Rosenberg, P.B., Mielke, M.M., Tschanz, J., Cook, L., Corcoran, C., Hayden, K.M., ... Lyketsos, C.G. (2008). Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. American Journal of Geriatric Psychiatry, 16, 883-892.
104. Ruitenberg, A., Ott, A., Van Swieten, J.C., Hofman, A. & Breteler, M.M. (2001). Incidence of dementia: Does gender make a difference Neurobiology of Aging, 22, 575-580.
105. Santanello, N.C., Barber, B.L., Applegate, W.B., Elam, J., Curtis, C., Hunninghake, D.B. & Gordon, D.J. (1997). Effect of pharmacologic lipid lowering on health-related quality of life in older persons: Results from the Cholesterol Reduction in Seniors Program (CRISP) pilot study. Journal of the American Geriatric Society, 45, 8-14.
106. Scarmeas, N., Stern, Y., Tang, M.X., Mayeux, R. & Luchsinger, J.A. (2006). Mediterranean diet and risk for Alzheimer's disease. Annals of Neurology, 59, 912-921.
107. Scharf, S., Mander, A., Ugoni, A., Vajda, F. & Christophidis, N. (1999). A double-blind, placebo-controlled trial of diclofenac/ misoprostol in Alzheimer's disease. Neurology, 53, 197-201.
108. Schmeidler, J., Mohs, R.C. & Aryan, M. (1998). Relationship of disease severity to decline on specific cognitive and functional measures in Alzheimer disease. Alzheimer Disease and Associated Disorders, 12, 146-151.
109. Seshadri, S., Zornberg, G.L., Derby, L.E., Myers, M.W., Jick, H. & Drachman, D.A. (2001). Postmenopausal estrogen replacement therapy and the risk of Alzheimer disease. Archives of Neurology, 58, 435-440.
110. Shah, K., Qureshi, S.U., Johnson, M., Parikh, N., Schulz, P.E. & Kunik, M.E. (2009). Does use of antihypertensive drugs affect the incidence or progression of dementia A systematic review. American Journal of Geriatric Pharmacotherapy, 7, 250-261.
111. Shao, H., Breitner, J.C., Whitmer, R.A., Wang, J., Hayden, K., Wengreen, H., ... Zandi, P.P. (2012). Hormone therapy and Alzheimer disease dementia: New findings from the Cache County Study. Neurology, 79, 1846-1852.
112. Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L., Buckley, B.M., Cobbe, S.M., ... Westendorp, R.G. (2002). Pravastatin in elderly individuals at risk of vascular disease (prosper): A randomised controlled trial. Lancet, 360, 1623-1630.
113. Shumaker, S.A., Legault, C., Kuller, L., Rapp, S.R., Thal, L., Lane, D.S., ... Coker, L.H. (2004). Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. Journal of the American Medical Association, 291, 2947-2958.
114. Shumaker, S.A., Legault, C., Rapp, S.R., Thal, L., Wallace, R.B., Ockene, J.K., ... Wactawski-Wende, J. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: The Women's Health Initiative Memory Study: A randomized controlled trial. Journal of the American Medical Association, 289, 2651-2662.
115. Slavin, M.J., Brodaty, H. & Sachdev, P.S. (2013). Challenges of diagnosing dementia in the oldest old population. Journals of Gerontology A Bioliological Sciences Medical Sciences, 68, 1103-1111.
116. Soininen, H., West, C., Robbins, J. & Niculescu, L. (2007). Longterm efficacy and safety of celecoxib in Alzheimer's disease. Dementia, and Geriatric Cognnitive Disorders, 23, 8-21.
117. Steffens, D.C., Norton, M.C., Plassman, B.L., Tschanz, J.T., Wyse, B.W., Welsh-Bohmer, K.A., ... Breitner, J.C. (1999). Enhanced cognitive performance with estrogen use in nondemented community-dwelling older women. Journal of the American Geriatrics Society 47, 1171-1175.
118. Steinberg, M., Hess, K., Corcoran, C., Mielke, M.M., Norton, M., Breitner, J., ... Tschanz, J. (2013). Vascular risk factors and neuropsychiatric symptoms in Alzheimer's disease: The Cache County Study. International Journal of Geriatric Psychiatry, doi: 10.1002/gps.3980
119. Steinberg, M., Shao, H., Zandi, P., Lyketsos, C.G., Welsh-Bohmer, K.A., Norton, M.C., ... Tschanz, J.T. (2008). Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: The Cache County Study. International Journal of Geriatric Psychiatry, 23, 170-177.
120. Steinberg, M., Tschanz, J.T., Corcoran, C., Steffens, D.C., Norton, M.C., Lyketsos, C.G. & Breitner, J.C. (2004). The persistence of neuropsychiatric symptoms in dementia: The Cache County Study. International Journal of Geriatric Psychiatry, 19, 19-26.
121. Stern, Y., Albert, S., Tang, M.X. & Tsai, W.Y. (1999). Rate of memory decline in AD is related to education and occupation: Cognitive reserve Neurology, 53, 1942-1947.
122. Swanwick, G.R., Coen, R.F., Coakley, D. & Lawlor, B.A. (1998). Assessment of progression and prognosis in ' possible'and probable'Alzheimer's disease. International Journal of Geriatric Psychiatry, 13, 331-335.
123. Tang, M.X., Jacobs, D., Stern, Y., Marder, K., Schofield, P., Gurland, B., ... Mayeux, R. (1996). Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet, 348, 429-432.
124. Treiber, K.A., Carlson, M.C., Corcoran, C., Norton, M.C., Breitner, J.C., Piercy, K.W., ... Tschanz, J.T. (2011). Cognitive stimulation and cognitive and functional decline in Alzheimer's disease: The Cache County Dementia Progression Study. Journals of Gerontology Psychological Sciences Social Sciences, 66, 416-425.
125. Treiber, K.A., Lyketsos, C.G., Corcoran, C., Steinberg, M., Norton, M., Green, R.C., ... Tschanz, J.T. (2008). Vascular factors and risk for neuropsychiatric symptoms in Alzheimer's disease: The Cache County Study. International Psychogeriatrics, 20, 538-553.
126. Tschanz, J.T., Corcoran, C., Schwartz, S., Treiber, K., Green, R.C., Norton, M.C., ... Lyketsos, C.G. (2011). Progression of cognitive, functional and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: The Cache County Dementia Progression Study. American Journal of Geriatric Psychiatry, 19, 532-542.
127. Tschanz, J.T., Pfister, R., Wanzek, J., Corcoran, C., Smith, K., Tschanz, B.T., ... Norton, M.C. (2013a). Stressful life events and cognitive decline in late life: Moderation by education and age. The Cache County Study. International Journal of Geriatric Psychiatry, 28, 821-830.
128. Tschanz, J.T., Piercy, K., Corcoran, C.D., Fauth, E., Norton, M.C., Rabins, P.V., ... Lyketsos, C.G. (2013b). Caregiver coping strategies predict cognitive and functional decline in dementia: The Cache County Dementia Progression Study. American Journal of Geriatric Psychiatry, 21, 57-66.
129. Tschanz, J.T., Treiber, K., Norton, M.C., Welsh-Bohmer, K.A., Toone, L., Zandi, P.P., ... Breitner, J.C. (2005). A population study of Alzheimer's disease: Findings from the Cache County Study on Memory, Health, and Aging. Care Management Journal, 6, 107-114.
130. Tschanz, J.T., Welsh-Bohmer, K.A., Lyketsos, C.G., Corcoran, C., Green, R.C., Hayden, K., ... Breitner, J.C. (2006). Conversion to dementia from mild cognitive disorder: The Cache County Study. Neurology, 67, 229-234.
131. Tuokko, H., Frerichs, R., Graham, J., Rockwood, K., Kristjansson, B., Fisk, J., ... Mcdowell, I. (2003). Five-year follow-up of cognitive impairment with no dementia. Archives of Neurology, 60, 577-582.
132. Tzourio, C., Anderson, C., Chapman, N., Woodward, M., Neal, B., Macmahon, S. & Chalmers, J. (2003). Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Archives of Internal Medicine, 163, 1069-1075.
133. UN (United Nations). (2002). World population ageing: 1950-2050. Retrieved from http://www.un.org/esa/population/publications/ worldageing19502050/
134. US Census. (1990). Retrieved from http://www.census.gov/population/ cencoutns/
135. Wengreen, H.J., Munger, R.G., Corcoran, C.D., Zandi, P., Hayden, K.M., Fotuhi, M., ... Welsh-Bohmer, K.A. (2007). Antioxidant intake and cognitive function of elderly men and women: The Cache County Study. Journal of Nutrition, Health and Aging, 11, 230-237.
136. Wengreen, H.J., Neilson, C., Munger, R. & Corcoran, C. (2009). Diet quality is associated with better cognitive test performance among aging men and women. Journal of Nutrition, 139, 1944-1949.
137. Whitmer, R.A., Quesenberry, C.P., Zhou, J. & Yaffe, K. (2011). Timing of hormone therapy and dementia: The critical window theory revisited. Annals of Neurology, 69, 163-169.
138. Whitmer, R.A., Sidney, S., Selby, J., Johnston, S.C. & Yaffe, K. (2005). Midlife cardiovascular risk factors and risk of dementia in late life. Neurology, 64, 277-281.
139. WHO-AD (Alzheimer's Disease) International (2012). Dementia: A Public Health Priority. Geneva: World Health Organization.
140. Wolozin, B., Kellman, W., Ruosseau, P., Celesia, G.G. & Siegel, G. (2000). Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. Archives of Neurology, 57, 1439-1443.
141. Yip, A.G., Green, R.C., Huyck, M., Cupples, L.A. & Farrer, L.A. (2005). Nonsteroidal anti-inflammatory drug use and Alzheimer's disease risk: The MIRAGE Study. British Medical Journal Geriatrics, 5, 2.
142. Zandi, P.P., Anthony, J.C., Hayden, K.M., Mehta, K., Mayer, L. & Breitner, J.C. (2002a). Reduced incidence of AD with NSAID but not H2 receptor
143. Zandi, P.P., Anthony, J.C., Khachaturian, A.S., Stone, S.V., Gustafson, D., Tschanz, J.T., ... Breitner, J.C. (2004). Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: The Cache County Study. Archives of Neurology, 61, 82-88.
144. Zandi, P.P., Carlson, M.C., Plassman, B.L., Welsh-Bohmer, K.A., Mayer, L.S., Steffens, D.C. & Breitner, J.C. (2002b). Hormone replacement therapy and incidence of Alzheimer disease in older women: The Cache County Study. Journal of the American Medical Association, 288, 2123-2129.
145. Zandi, P.P., Sparks, D.L., Khachaturian, A.S., Tschanz, J., Norton, M., Steinberg, M., ... Breitner, J.C. (2005). Do statins reduce risk of incident dementia and Alzheimer Disease The Cache County Study. Archives of General Psychiatry, 62, 217-224.